Rigel Pharmaceuticals Eulerpool Nyheder

Rigel Pharmaceuticals Eulerpool News

Rigel Pharmaceuticals Aktie Nyheder

Rigel Pharmaceuticals bliver overvåget af mange journalister og investorer over hele verden. De seneste Rigel Pharmaceuticals nyheder samler vi her.

• 12. september ·

  Yahoo
  Rigel to Present at the 2024 Cantor Global Healthcare Conference
• 6. september ·

  Yahoo
  Rigel enrols first participant in Phase Ib/II AML treatment regimen trial
• 5. september ·

  Yahoo
  Rigel Announces First Patient Enrolled in Phase 1b/2 Triplet Therapy Trial of REZLIDHIA® (olutasidenib) in mIDH1 AML
• 5. september ·

  PR Newswire
  Rigel Announces First Patient Enrolled in Phase 1b/2 Triplet Therapy Trial of REZLIDHIA? (olutasidenib) in mIDH1 AML
• 5. september ·

  Thefly.com
  Rigel Pharmaceuticals: First patient enrolled in Phase 1b/2 REZLIDHIA trial
• 3. september ·

  Yahoo
  Rigel Expands Relationship with Kissei to include REZLIDHIA® (olutasidenib) in Japan, the Republic of Korea and Taiwan
• 3. september ·

  TipRanks
  Buy Rating Affirmed for Rigel with Positive Outlook on Asian Market Expansion and Solid NPV Valuation
• 3. september ·

  PR Newswire
  Rigel Expands Relationship with Kissei to include REZLIDHIA? (olutasidenib) in Japan, the Republic of Korea and Taiwan
• 3. september ·

  Thefly.com
  Rigel Pharmaceuticals enters license and supply agreement with Kissei Pharma
• 29. august ·

  Yahoo
  With 45% stake, Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) seems to have captured institutional investors' interest